Neuronyx

Neuronetics is a leading medical technology company dedicated to transforming neurohealth through innovative, non-invasive treatments for psychiatric disorders, particularly major depressive disorder. Their flagship product, NeuroStar Advanced Therapy, is the industry's most clinically supported transcranial magnetic stimulation (TMS) treatment, aiming to improve quality of life for patients who have not found relief through traditional antidepressant medications.

With a commitment to patient-centric care, Neuronetics strives to foster practice success by providing exceptional support and expanding treatment capabilities. The company emphasizes collaboration and compassion, driven by a mission to inspire positive change in patients' lives and the broader mental health community.

Generated from the website